ALIX ZACKON: Open Payments
NPI 1689309205 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,425 in 96 payments from 22 companies in 2025. Trend: 2023 $1,368 · 2024 $2,777 · 2025 $2,425
Food & beverage: $2,374Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $481 |
| Madrigal Pharmaceuticals | 10 | $345 |
| Janssen Biotech, Inc. | 9 | $343 |
| Lilly USA, LLC | 12 | $207 |
| Regeneron Healthcare Solutions, Inc. | 3 | $166 |
| Celltrion USA Inc. | 6 | $161 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| GENZYME CORPORATION | 3 | $97 |
| Napo Pharmaceuticals Inc | 3 | $73 |
| QOL Medical, LLC | 2 | $56 |
Products named: REZDIFFRA, TREMFYA, OMVOH, SKYRIZI, VEGZELMA, DUPIXENT, RINVOQ, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
